Brief: Taisho Pharmaceutical Holdings unit signs agreement regarding allergic disease therapeutic agent
July 15 (Reuters) - Taisho Pharmaceutical Holdings Co Ltd
4581.T :
* Says its unit Taisho Pharmaceutical signed agreement
(contract for the license and commercialization) for an allergic
disease therapeutic agent regarding OTC drugs in Japan with
Bayer Yakuhin, Ltd., on July 11
Source text in Japanese: https://goo.gl/8HO9gZ
Further company Coverage: 4581.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10